Welcome to Hologic Investor Relations

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems for breast and skeletal heath, GYN surgical products and medical aesthetic systems. With a broad range of market-leading technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Thursday, June 8, 2017

Conference Call Dial-in Numbers: 877-780-3379 (U.S.) 719-325-2435 (international) Access code: 9898213 Click here for Replay

Recent News
Jul 5, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2017 on Wednesday, August 2, 2017, after the market closes. In...

Jul 3, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust...

Jun 29, 2017

Hologic, Inc. (Nasdaq: HOLX) has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory testing, the Company announced today. The Fusion...

Jun 20, 2017

MARLBOROUGH, Mass. (June 20, 2017) – Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima® Combo 2® Assay for Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhoea)...

More ›